The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation

Cancer Gene Therapy

Volumn 17, Issue 10, 2010, Pages 700-707

  Li, H ^a,c   Shi, X ^b,d   Liu, J ^b   Hu, C ^b   Zhang, X ^b,e   Liu, H ^b   Jin, J ^b   Opolon, P ^c   Vannier, J P ^a   Perricaudet, M ^c   Janin, A ^b   Soria, C ^a,b   Lu, H ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d NANCHANG UNIVERSITY   (China)

^e INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

antiangiogenesis; colon cancer; endothelial; N terminal fragment; VE cadherin

Indexed keywords

MATRIGEL; VASCULAR ENDOTHELIAL CADHERIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON CANCER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD; CADHERINS; CELL PROLIFERATION; CELLS, CULTURED; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MICE, NUDE; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS; MUS MUSCULUS;

EID: 77956886193     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2010.26     Document Type: Article

References (38)

1. Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, Wu Y et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 2002; 62: 2567-2575.
2. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J et al. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium- specific cadherin. Arterioscler Thromb Vasc Biol 1995; 15: 1229-1239.
3. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98: 147-157.
4. Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino D et al. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest 1996; 98: 886-893.
5. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1997; 100: S7-10.
6. Heimark RL, Schwartz SM. The role of membranemembrane interactions in the regulation of endothelial cell growth. J Cell Biol 1985; 100: 1934-1940.
7. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 2001; 97: 1679-1684.
8. Gory S, Dalmon J, Prandini MH, Kortulewski T, de Launoit Y, Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem 1998; 273: 6750-6755.
9. Hulsken J, Behrens J, Birchmeier W. Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr Opin Cell Biol 1994; 6: 711-716.
10. Breier G, Breviario F, Caveda L, Berthier R, Schnurch H, Gotsch U et al. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 1996; 87: 630-641.
11. Suzuki S, Sano K, Tanihara H. Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul 1991; 2: 261-270.
12. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 1995; 129: 203-217.
13. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E. Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem 1995; 270: 30965-30972.
14. Herren B, Levkau B, Raines EW, Ross R. Cleavage of betacatenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell 1998; 9: 1589-1601.
15. Shay-Salit A, Shushy M, Wolfovitz E, Yahav H, Breviario F, Dejana E et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc Natl Acad Sci USA 2002; 99: 9462-9467.
16. Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F et al. Contact inhibition of VEGFinduced proliferation requires vascular endothelial cadherin, b-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003; 161: 793-804.
17. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004; 5: 261-270.
18. Corada L, Zanetta F, Orsenigo F, Breviario MG, Lampugnani S, Bernasconi F et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 2002; 100: 905-911.
19. Li H, Lu H, Griscelli F, Opolon P, Sun LQ, Ragot T et al. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Therapy 1998; 5: 1105-1113.
20. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther 2001; 12: 515-526.
21. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
22. Mekid H, Mir LM. In vivo cell electrofusion. Biochim Biophys Acta 2000; 1524: 118-130.
23. Lenz HJ. Antiangiogenic agents in cancer therapy. Oncology (Williston Park) 2005; 19(4 Suppl 3): 17-25.
24. Cooney MM, van Heeckeren W, Bhakta S, Ortiz J, Remick SC. Drug insight: vascular disrupting agents and angiogenesis- novel approaches for drug delivery. Nat Clin Pract Oncol 2006; 3: 682-692.
25. Waxman DJ. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 2008; 7: 3670-3684.
26. Bergers G, Hanahan D. Modes of resistance to antiangiogenic therapy. Nat Rev Cancer 2008; 8: 592-603.
27. Liao F, Li Y, OConnor W, Zanetta L, Bassi R, Santiago A et al. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res 2000; 60: 6805-6810.
28. Shi XY, Lu H, Li WL, Tang HL, Xiong JJ, Zhang JQ et al. A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition. J Cancer Res Clin Oncol 2006; 132: 561-571.
29. Rahimi N, Kazlauskas A. A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells. Mol Biol Cell 1999; 10: 3401-3407.
30. Cavallaro U, Liebner S, Dejana E. Endothelial cadherins and tumor angiogenesis. Exp Cell Res 2006; 312: 659-667.
31. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 2006; 174: 593-604.
32. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003; 106: 871-878.
33. Vincent L, Kermani P, Young LM, Cheng J, Zhang F, Shido K et al. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J Clin Invest 2005; 115: 2992-3006.
34. Matsumura T, Wolff K, Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 1997; 158: 3408-3416.
35. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in threedimensional collagen gels. Am J Pathol 1999; 155: 887-895.
36. Menon C, Ghartey A, Canter R, Feldman M, Fraker DL. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin. Ann Surg 2006; 244: 781-791.
37. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 2006; 118: 1635-1644.
38. Zanetta L, Corada M, Grazia Lampugnani M, Zanetti A, Breviario F et al. Downregulation of vascular endothelialcadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications. Thromb Haemost 2005; 93: 1041-1046.